De Novo device
eXciteOSA with remote and eXciteOSA without remote
Signifier Medical Technologies · Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea (QNO, Class II) · First FDA decision Feb 5, 2021, newest Feb 5, 2021Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
5
Naming "eXciteOSA"
MAUDE reports
9
Brand "eXciteOSA", since 2015
PubMed studies
6
Mentioning "eXciteOSA"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- eXciteOSA with remote and eXciteOSA without remoteNew device typeDe Novo
DEN200018 · Decided Feb 5, 2021 · 318 days after receipt
Device type: Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea (QNO) · Dentistry & Oral Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sleep Testing for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00405NUpdated Sep 23, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093R2Updated Sep 17, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093RUpdated Sep 17, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093NUpdated Sep 15, 2026
- Sleep Testing for Obstructive Sleep Apnea (OSA)National determinationOn the books240.4.1Updated Nov 17, 2023
- Continuous Positive Airway Pressure (CPAP) Therapy For Obstructive Sleep Apnea (OSA)National determinationOn the books240.4Updated Aug 17, 2023
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38387Wellpoint FederalUpdated Jul 14, 2026
- Hypoglossal Nerve Stimulation for Obstructive Sleep ApneaLocal determinationIn effectL38276Palmetto GBAUpdated May 8, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "eXciteOSA", any status and sponsor, newest update first.
- Different Forms of OMT as Methods for Reducing Snoring and Mild to Moderate Sleep ApneaPivotal-lookingEnrolling by invitation
Region VästerbottenGovernment (non-federal)
NCT06330116 · 141 participants (planned) · Start May 1, 2024 · Primary completion Dec 31, 2025
Device: IQoro; eXciteosa · For: Sleep Apnea, Obstructive; Snoring
Sites: Köge, Denmark; Lund, Sweden; Umeå, Sweden
University of MiamiAcademic, hospital or other
NCT04974515 · 40 participants · Start Aug 17, 2021 · Primary completion Oct 31, 2022
Device: eXciteOSA · For: Obstructive Sleep Apnea
Sites: Miami, Florida
Signifier Medical TechnologiesNot on our public-company list
NCT05252156 · 62 participants · Start Mar 21, 2022 · Primary completion Oct 26, 2022
Device: eXciteOSA · For: Sleep Apnea, Obstructive
Sites: Birmingham, Alabama; Colorado Springs, Colorado; Lehigh Acres, Florida · 7 sites in all
- eXciteOSA for Treatment of Mild Obstructive Sleep ApneaPivotal-lookingStatus unknown
Signifier Medical TechnologiesNot on our public-company list
NCT05183009 · 102 participants · Start Jan 17, 2022 · Primary completion Dec 31, 2022
Device: eXciteOSA · For: Sleep Apnea, Obstructive
Sites: Birmingham, Alabama; Colorado Springs, Colorado; Lehigh Acres, Florida · 7 sites in all
- Efficacy of Intra-oral Neuromuscular Stimulation Training on Snoring and Mild Sleep ApnoeaStatus unknown
Signifier Medical TechnologiesNot on our public-company list
NCT04392765 · 200 participants (planned) · Start May 11, 2020 · Primary completion Dec 30, 2022
Device: eXciteOSA · For: Snoring; Sleep Apnea, Obstructive
Sites: Vancouver, Canada; Montreal, Canada; Berlin, Germany · 6 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "eXciteOSA", and for the whole product code for context.
This brand
9 reports: 3 malfunction, 5 injury, 0 death
Whole product code QNO
10 reports: 4 malfunction, 5 injury, 0 death
Newest reports for this brand
- EXCITEOSAInjury
SIGNIFIER MEDICAL TECHNOLOGIES LIMITED
MW5165450 · Received Jan 30, 2025 · Event dated Nov 1, 2024
Device type: Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea (QNO)
Patient problem as coded: Apnea; Fatigue; Sleepiness/Drowsiness/Somnolence
- EXCITEOSAInjury
SIGNIFIER MEDICAL TECHNOLOGIES
3017737771-2023-00028 · Received Dec 22, 2023
Device type: Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea (QNO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Difficulty Chewing
- EXCITEOSAInjury
SIGNIFIER MEDICAL TECHNOLOGIES
3017737771-2023-00033 · Received Jul 28, 2023 · Event dated Jun 30, 2023
Device type: Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea (QNO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bruise/Contusion; Undesired Nerve Stimulation; Pain
- EXCITEOSAMalfunction
MW5118989 · Received Jun 28, 2023 · Event dated Jun 25, 2023
Device type: Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea (QNO)
Device problem as coded: Product Quality Problem; Device Markings/Labelling Problem
Patient problem as coded: Insufficient Information
- EXCITEOSAInjury
SIGNIFIER MEDICAL TECHNOLOGIES
3017737771-2022-00021 · Received Nov 6, 2022 · Event dated Oct 7, 2022
Device type: Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea (QNO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem
Patient problem as coded: Sensitivity of Teeth; Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "eXciteOSA"[tiab]. The summary above synthesizes these.
- Inspire for obstructive sleep apnea.
Med Lett Drugs Ther · 2023
- Transoral neuromuscular electrical stimulation therapy adherence and intensity levels in veterans with mild OSA.
Stepnowsky C, Zamora T, Velazquez Y, et al. · Sleep Adv · 2026
- Tirzepatide (Zepbound) for obstructive sleep apnea.
Med Lett Drugs Ther · 2025
- Daytime Neuromuscular Electrical Therapy of Tongue Muscles in Improving Snoring in Individuals with Primary Snoring and Mild Obstructive Sleep Apnea.
Baptista PM, Martínez Ruiz de Apodaca P, Carrasco M, et al. · J Clin Med · 2021
- Intraoral Neuromuscular Stimulation Device and Rapid Eye Movement-Dependent Obstructive Sleep Apnea.
Wasey W, Manahil N, Wasey N, et al. · Cureus · 2022Case Reports
- New non-invasive electrical stimulation devices for treatment of snoring and obstructive sleep apnoea: a systematic review.
Moffa A, Giorgi L, Carnuccio L, et al. · Sleep Breath · 2023Systematic Review
Other devices of this type
Also filed under product code QNO.
- eXciteOSA without remote control (3000)Signifier Medical Technologies, Ltd. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.